Vita Life Sciences Management
Management criteria checks 3/4
Vita Life Sciences' CEO is Andrew O'Keefe, appointed in Jan 2017, has a tenure of 7.83 years. total yearly compensation is A$886.73K, comprised of 49.8% salary and 50.2% bonuses, including company stock and options. directly owns 1.58% of the company’s shares, worth A$1.85M. The average tenure of the management team and the board of directors is 7.7 years and 5 years respectively.
Key information
Andrew O'Keefe
Chief executive officer
AU$886.7k
Total compensation
| CEO salary percentage | 49.8% |
| CEO tenure | 7.8yrs |
| CEO ownership | 1.6% |
| Management average tenure | 7.7yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | AU$9m |
| Mar 31 2024 | n/a | n/a | AU$9m |
| Dec 31 2023 | AU$887k | AU$442k | AU$9m |
| Sep 30 2023 | n/a | n/a | AU$8m |
| Jun 30 2023 | n/a | n/a | AU$7m |
| Mar 31 2023 | n/a | n/a | AU$7m |
| Dec 31 2022 | AU$984k | AU$438k | AU$7m |
| Sep 30 2022 | n/a | n/a | AU$8m |
| Jun 30 2022 | n/a | n/a | AU$8m |
| Mar 31 2022 | n/a | n/a | AU$8m |
| Dec 31 2021 | AU$653k | AU$442k | AU$8m |
| Sep 30 2021 | n/a | n/a | AU$8m |
| Jun 30 2021 | n/a | n/a | AU$7m |
| Mar 31 2021 | n/a | n/a | AU$6m |
| Dec 31 2020 | AU$510k | AU$440k | AU$6m |
| Sep 30 2020 | n/a | n/a | AU$6m |
| Jun 30 2020 | n/a | n/a | AU$5m |
| Mar 31 2020 | n/a | n/a | AU$4m |
| Dec 31 2019 | AU$535k | AU$442k | AU$3m |
| Sep 30 2019 | n/a | n/a | AU$2m |
| Jun 30 2019 | n/a | n/a | AU$2m |
| Mar 31 2019 | n/a | n/a | AU$2m |
| Dec 31 2018 | AU$424k | AU$421k | AU$2m |
| Sep 30 2018 | n/a | n/a | AU$3m |
| Jun 30 2018 | n/a | n/a | AU$4m |
| Mar 31 2018 | n/a | n/a | AU$3m |
| Dec 31 2017 | AU$445k | AU$408k | AU$3m |
Compensation vs Market: Andrew's total compensation ($USD574.61K) is above average for companies of similar size in the Australian market ($USD298.48K).
Compensation vs Earnings: Andrew's compensation has been consistent with company performance over the past year.
CEO
Andrew O'Keefe
7.8yrs
Tenure
AU$886,732
Compensation
Mr. Andrew W. O'Keefe has been Managing Director and Director of Vita Life Sciences Limited since January 1, 2017. Mr. O'Keefe served as Acting Managing Director of Vita Life Sciences Limited since October...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 7.8yrs | AU$886.73k | 1.58% A$ 1.8m | |
| CFO & Company Secretary | 7.5yrs | AU$365.80k | 0.99% A$ 1.2m | |
| Group Marketing Manager | 7.8yrs | AU$175.02k | 0.31% A$ 363.1k | |
| Chief Executive Officer of Australia | no data | AU$521.94k | 0.93% A$ 1.1m | |
| Chief Executive Officer of Vita Life Sciences Malaysia & Singapore | 5.3yrs | AU$545.55k | 1.07% A$ 1.3m | |
| General Manager of Operations & Business Support | no data | no data | no data | |
| Technical & NPD Manager | no data | no data | no data |
7.7yrs
Average Tenure
Experienced Management: VLS's management team is seasoned and experienced (7.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 7.8yrs | AU$886.73k | 1.58% A$ 1.8m | |
| Non-Executive Chairman | 12.9yrs | AU$136.90k | 0.77% A$ 897.0k | |
| Independent Non-Executive Director | 1.3yrs | AU$16.67k | 0.045% A$ 52.4k | |
| Non-Executive Director | 2.2yrs | AU$37.21k | no data |
5.0yrs
Average Tenure
Experienced Board: VLS's board of directors are considered experienced (5 years average tenure).